Industry Voices and Cannabis News | Page 105 of 135 | Cannabiz

Medlab still in limbo as talks continue with ‘interested parties’

by Steve Jones June 7, 2023April 30, 2024

The future of Medlab Clinical remains uncertain as the company continues to explore restructuring options. Shareholders […]

Scrutiny of SAS-B data for psychiatric conditions exposes prescribing ‘disconnect’

by Steve Jones June 7, 2023April 30, 2024

Montu caught in second product dispute over ‘out of stock’ claims

by Steve Jones June 7, 2023April 30, 2024

Creso Pharma eyes Australian market as firm seeks GMP licence

by Steve Jones June 6, 2023April 30, 2024

‘It all starts with flower’: Tasmanian Botanics takes local road to long-term success

by Steve Jones June 5, 2023April 30, 2024

Medical Form On Table Diagnosis Epilepsy - Medical Cannabis - Cannabiz

Lennox-Gastaut syndrome becomes second Epidyolex indication to be listed on PBS

by Steve Jones June 5, 2023April 30, 2024

Creditors advised to wind up BBS Pharmaceuticals as investigations continue into firm’s financial affairs

by Steve Jones June 1, 2023April 30, 2024

Overseas manufacturers in bid to supply non-compliant product for ‘limited period’ beyond July 1

by Steve Jones May 31, 2023April 30, 2024

Bod Science to test drug-delivery tech on psychiatric medication

by Steve Jones May 31, 2023April 30, 2024

NZ study finds cannabis users reduced reliance on opioid medication

by Steve Jones May 30, 2023April 30, 2024